A Randomized, Double‐Blind, Placebo‐Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti‐FGF23 Antibody, in Adults With X‐Linked Hypophosphatemia: Week 24 Primary Analysis
K. Insogna, K. Briot, E. Imel, P. Kamenickỷ +17 more
Researcher profile · Semantic Scholar
K. Insogna, K. Briot, E. Imel, P. Kamenickỷ +17 more
L. Mucke, E. Masliah, W. Johnson, M. Ruppe +6 more
T. Carpenter, E. Imel, M. Ruppe, T. Weber +8 more
T. Wyss-Coray, Li-Li Feng, E. Masliah, M. Ruppe +4 more
E. Imel, Xiao-Ping Zhang, M. Ruppe, T. Weber +9 more
T. Brown, M. Ruppe, R. Kassner, Princy N. Kumar +3 more
Spandana J Brown, M. Ruppe, L. Tabatabai
W. Johnson, M. Ruppe, E. Rockenstein, J. Price +3 more
M. Ruppe, Xiao-Ping Zhang, E. Imel, T. Weber +9 more
M. Ruppe, P. G. Brosnan, Kit-Sing Au, Phong X. Tran +2 more
Xiao-Ping Zhang, E. Imel, M. Ruppe, T. Weber +9 more
M. Ruppe, Stephen A. Huang, S. Jan de Beur
Patricia Mejía Osuna, M. Ruppe, L. Tabatabai
C. Landry, M. Ruppe, E. Grubbs
D. Satgé, E. Philippe, M. Ruppe, J. Lévy +2 more
J. Loyer, E. Murphy, M. Ruppe, V. Moiseyev +6 more
M. Ruppe, M. Zeiger, S. D. de Beur